Dextrose Monohydrate 10% Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dextrose Monohydrate 10% Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Mar 1, 2022. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-824-76
- Dosage Form
- Injection
- Presentation
- Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)
- Initial Posting
- Mar 1, 2022
Reason
Demand increase for the drug